The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa
about
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The potential cost and benefit ...... ts in Nigeria and South Africa
@ast
The potential cost and benefit ...... ts in Nigeria and South Africa
@en
The potential cost and benefit ...... ts in Nigeria and South Africa
@nl
type
label
The potential cost and benefit ...... ts in Nigeria and South Africa
@ast
The potential cost and benefit ...... ts in Nigeria and South Africa
@en
The potential cost and benefit ...... ts in Nigeria and South Africa
@nl
prefLabel
The potential cost and benefit ...... ts in Nigeria and South Africa
@ast
The potential cost and benefit ...... ts in Nigeria and South Africa
@en
The potential cost and benefit ...... ts in Nigeria and South Africa
@nl
P2093
P2860
P50
P1433
P1476
The potential cost and benefit ...... ts in Nigeria and South Africa
@en
P2093
Chidi Nwizu
David A Cooper
David P Wilson
Jonathan Anderson
Karen Schneider
P2860
P304
P356
10.1371/JOURNAL.PONE.0054435
P407
P577
2013-02-15T00:00:00Z